Crescent Capital BDC (CCAP) Scheduled to Post Quarterly Earnings on Monday

Crescent Capital BDC (NASDAQ:CCAP) is scheduled to be releasing its earnings data after the market closes on Monday, November 11th. Analysts expect Crescent Capital BDC to post earnings of $0.57 per share for the quarter. Investors interested in listening to the company’s conference call can do so using this link.

Crescent Capital BDC (NASDAQ:CCAP) last announced its quarterly earnings results on Monday, August 12th. The company reported $0.59 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.58 by $0.01. Crescent Capital BDC had a return on equity of 12.03% and a net margin of 51.61%. The firm had revenue of $48.95 million for the quarter, compared to the consensus estimate of $48.05 million. During the same period in the prior year, the company posted $0.56 earnings per share. On average, analysts expect Crescent Capital BDC to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Crescent Capital BDC Price Performance

NASDAQ CCAP opened at $18.30 on Friday. Crescent Capital BDC has a one year low of $15.91 and a one year high of $19.63. The stock has a 50-day moving average of $18.38 and a 200 day moving average of $18.37. The company has a debt-to-equity ratio of 1.17, a quick ratio of 1.40 and a current ratio of 1.40. The company has a market capitalization of $678.20 million, a price-to-earnings ratio of 6.65 and a beta of 0.81.

Crescent Capital BDC Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, October 15th. Stockholders of record on Monday, September 30th were issued a dividend of $0.42 per share. This represents a $1.68 dividend on an annualized basis and a dividend yield of 9.18%. The ex-dividend date was Monday, September 30th. This is an increase from Crescent Capital BDC’s previous quarterly dividend of $0.09. Crescent Capital BDC’s dividend payout ratio (DPR) is presently 61.09%.

Wall Street Analyst Weigh In

CCAP has been the topic of a number of research analyst reports. LADENBURG THALM/SH SH began coverage on shares of Crescent Capital BDC in a research report on Monday, September 30th. They set a “buy” rating and a $20.00 price objective on the stock. Wells Fargo & Company lowered their price target on Crescent Capital BDC from $19.00 to $18.00 and set an “equal weight” rating on the stock in a report on Wednesday, August 14th. Finally, Bank of America cut their price objective on Crescent Capital BDC from $20.00 to $19.00 and set a “buy” rating for the company in a report on Thursday, August 15th. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $19.00.

Crescent Capital BDC Company Profile

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.